| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 56.8 | 58.7 | 41.3 |
| Other income | 2.9 | 0.7 | 0.3 |
| Total income | 59.7 | 59.4 | 41.6 |
| Profit before exceptional items & tax | 8.3 | 3.8 | 5.7 |
| Profit before tax | 8.3 | 3.8 | 5.7 |
| Net profit | 5.9 | 2.9 | 4.3 |
| Operating margin | 13.9% | 6.4% | 13.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +37.20% |
|---|---|
| Net profit, quarter on quarter | +103.40% |
| Revenue, year on year | +37.50% |
BSE results filing, NSE: MEDICO. Figures extracted from the filing.
Medico Remedies Ltd: key numbers
- Share price
- ₹26.00
- Market cap
- ₹215.8 Cr
- Revenue (annual)
- ₹206.4 Cr
- Net profit (annual)
- ₹13.12 Cr
- P/E (TTM)
- 15.6×Sector 50.4×
- Promoter holding
- 61.38%+0.00% QoQ
- FII holding
- 0.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medico Remedies Ltd
All →Medico Remedies Annual General Meeting
Medico Remedies Ltd held its 32nd Annual General Meeting on September 22, 2026, transacting ordinary and special business, including director re-appointments and remuneration revisions.
Medico Remedies Q1 FY27 Results: Net Profit ₹2.5 Cr, Up 38.9% YoY
Medico Remedies Ltd reported revenue from operations of ₹69.4 Cr (+81.2% YoY) and net profit of ₹2.5 Cr (+38.9% YoY) for Q1 FY27.
- Key figure
- Net profit ₹2.5 Cr · +38.9% YoY